From the Editor-In-Chief
The U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
A Matter of Age | Alternatives to Opioids | Treating Head and Neck Skin Cancers | In Women, Lung Cancer Rates Are Rising Worldwide | Breaking Down Breakthrough Cancer Therapies | The Devastating Impact of Muscle Wasting | What’s Next?
Your Cancer Guide
Deciding when and what to worry about can help with gaining control over fear.
by Hester Hill Schnipper
Caregiving with Confidence
Healthy sleep habits should be an important part of self-care for caregivers.
by Aimee Swartz
Let your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
New tools are being integrated into the research process to ease patients’ access to clinical trials and improve their experience.
by Bradley Jones
Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.
by Kate Yandell
Cancer and its treatment can hinder sexual intimacy, but help is available. Talking about the problem is the first step.
by Cameron Walker
Carb Connection | Make Your Move
Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.
Experts offer advice on accompanying a friend to a doctor’s appointment, responding to a no evidence of disease diagnosis, and sharing the results of genetic testing.
The End of Treatment Bells fundraiser helps patients mark milestones.
by Sophy Ziss
Readers share snapshots of their lives today.
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR